The American Journal of Medicine
Volume 120, Issue 10, Supplement 1 , Pages S4-S5, October 2007

Cubicin Outcomes Registry and Experience (CORE) Methodology

  • Kenneth V.I. Rolston, MD

      Affiliations

    • M. D. Anderson Cancer Center, University of Texas, Houston, Texas, USA
    • ,
  • John Segreti, MD

      Affiliations

    • Rush University Medical Center, Chicago, Illinois, USA
    • ,
  • Kenneth C. Lamp, PharmD

      Affiliations

    • Cubist Pharmaceuticals, Inc., Lexington, Massachusetts, USA.
    • Corresponding Author InformationRequests for reprints should be addressed to Kenneth C. Lamp, PharmD, Cubist Pharmaceuticals, Inc., 65 Hayden Avenue, Lexington, Massachusetts 02421.
    • ,
  • Lawrence V. Friedrich, PharmD

      Affiliations

    • Cubist Pharmaceuticals, Inc., Lexington, Massachusetts, USA.

Abstract 

The Cubicin Outcomes Registry and Experience (CORE), was designed to retrospectively collect the real-world postmarking experience of patients who received daptomycin. A standardized case report form was used by trained investigators from 45 institutions across the United States. Data on 1,160 patients from November 2003 until December 2004 were collected on demographics, infections, treatments and outcomes at the end of daptomycin therapy. The data from CORE 2004 provide insight into the early clinical use of daptomycin.

Keywords: Bacteremia, Daptomycin, Right-sided endocarditis, Skin and skin-structure infections

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Please see the Author Disclosure section at the end of this article.

PII: S0002-9343(07)00658-4

doi:10.1016/j.amjmed.2007.07.008

The American Journal of Medicine
Volume 120, Issue 10, Supplement 1 , Pages S4-S5, October 2007

Article Tools